MODERNA INC. DL-,0001 WKN: A2N9D9 ISIN: US60770K1079 Forum: Aktien Thema: Hauptdiskussion

Ach wie ist das schön 🤗… so viele Neider hier aber bleibt uns weiterhin treu und schaut zu wie wir Money machen 😘

Leute vielleicht die noch mehr an das Unternehnen glauben.

Interessant: Pfizer, Moderna lose bids to escape Bayer US mRNA patent lawsuit 21:38 28/09/2026 By Blake Brittain Sept 28 (Reuters) - A federal judge in Delaware on Monday rejected Pfizer , BioNTech and Moderna's requests to dismiss patent lawsuits filed against them by Bayer's Monsanto unit over the messenger RNA technology used in their COVID-19 vaccines. US Circuit Judge William Bryson, sitting at the court by designation, said that the vaccine makers failed to show at an early stage of the case that the patent at issue was invalid or not infringed by their shots Spokespeople for the vaccine makers did not immediately respond to requests for comment on the decision "We are pleased with the court’s decision and remain confident in our position that Bayer’s patented innovations were used without authorization," Bayer said in a statement Bayer sued the companies in January for allegedly copying technology developed by Monsanto in the 1980s for strengthening mRNA in crops and using it to stabilize the genetic material in their vaccines The vaccine makers argued that their manufacturing processes worked differently than Bayer's technology Moderna also argued that the patent covered an unpatentable "law of nature" Bayer has also filed a separate lawsuit against Johnson & Johnson over the patent in New Jersey. The case is ongoing.

Ai, ai: Analysts Offer Insights on Healthcare Companies: Inventiva (IVA) and Moderna (MRNA) TipRanks Newsroom Sep 29, 2026, 07:00 AM Moderna (MRNA) J.P. Morgan analyst Jessica Fye maintained a Sell rating on Moderna yesterday. The company’s shares closed last Monday at $197.28. According to TipRanks.com, Fye is a 4-star analyst with an average return of 4.8% and a 52.6% success rate. Fye covers the Healthcare sector, focusing on stocks such as BioMarin Pharmaceutical, Vertex Pharmaceuticals, and Mirum Pharmaceuticals. Moderna has an analyst consensus of Hold, with a price target consensus of $109.19.

wenn du danach gehst, schreibe mit di marco ( das kleine Würstchen) und der weiße Hai( dauerbreit)

Aber man kann doch auch schwachsinn schreiben wie in anderen Foren.Ich finde die Beiträge immer sehr Lustig.Besonders die von den Verlierern.

na ja, alle Leute stehen verwundert an der Seitenlinie und trauen ihren Augen nicht!

Warum wird hier im Forum nix geschrieben alle ausser Haus oder noch andere verpflichtungen?

Kommt von unserer Generation Z die Schulabbrecher.Besser wird es auch nicht mehr.Es lebe die Verlödung der Menschheit.

Interessant: https://www.fool.com/investing/2026/09/28/moderna-vs-biontech-which-mrna-cancer-stock-has-mo/?source=djc&utm_source=djc&utm_medium=feed&utm_campaign=article&referring_guid=db07b8dc-9bde-41be-aec9-c6eae3619fd9&mod=mw_quote_news

Moderna Hits a Fresh 52-Week High Shares touched roughly $198 intraday, clearing the stock’s previous 52-week peak of $195.71. That strength builds on a big move from Thursday, when shares climbed nearly 7% after regulators overseeing this year’s European Society for Medical Oncology Congress accepted three research abstracts covering Moderna’s experimental cancer treatment, intismeran autogene, ahead of the event’s late-October run in Madrid. The headline abstract, slotted into the conference’s Presidential Symposium, covers late-stage trial results combining intismeran with Merck’s Keytruda in melanoma patients. Bernstein Remains Skeptical Despite the Rally Not everyone on Wall Street is convinced the rally is justified, though. Bernstein SocGen Group’s Courtney Breen kept a Market Perform rating and $45 price target in place, a figure sitting well below where shares actually trade, even while acknowledging that intismeran has done more than anything else to validate the broader promise of mRNA-based cancer treatments. https://www.benzinga.com/trading-ideas/movers/26/09/62000346/moderna-stock-reached-new-52-week-high-whats-happening?mod=mw_quote_news

Abverkauf hat begonnen. Das ist erst der Anfang 🤭 Heute habe ich gut verdient